HCLC — Health-Chem Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -98.36% | ||
| Return on Equity | -114.97% | ||
| Operating Margin | -11.23% | ||
Financial Summary
| Year End 31st Dec | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998E | 1999E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 44.87 | 46.93 | 46.54 | 47.56 | 37.72 | n/a | n/a | -0.52% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +50.34 | -36.73 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Health-Chem Corporation conducts its business primarily through its 90%-owned subsidiary, Transderm Laboratories Corporation. Transderm owns 98.5% of Hercon Laboratories Corporation, which develops and manufactures controlled release products for the pharmaceutical industry, at Transderm's Pennsylvania facility, to deliver a variety of drugs topically or transdermally. The Company has manufactured over-the-counter pharmaceutical and cosmetic products that are used to clean facial pores. These deep cleansing facial pore strips are designed to remove clogged dirt, oil and blackheads from the nose, chin, forehead and anywhere else on the face that needs deep cleaning. In addition to its nitroglycerin transdermal products, the Company is also developing transdermal products for hormone replacement therapies.
Directors
- Last Annual
- December 31st, 1997
- Last Interim
- September 30th, 1998
- Incorporated
- December 28th, 1970
- Public Since
- July 2nd, 1971
- No. of Employees
- 206
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 12,330,924
- Address
- 460 Park Ave Rm 1300, NEW YORK, 10022-1861
- Web
- Phone
- +1 2127515600
- Auditors
- Coopers & Lybrand
Similar to HCLC
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
FAQ
As of Today at 15:49 UTC, shares in Health-Chem are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Health-Chem last closed at $0.00 and the price had moved by -99% over the past 365 days. In terms of relative price strength the Health-Chem share price has underperformed the S&P500 Index by -99.18% over the past year.
There is no consensus recommendation for this security.
Health-Chem does not currently pay a dividend.
Health-Chem does not currently pay a dividend.
Health-Chem does not currently pay a dividend.
To buy shares in Health-Chem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Health-Chem had a market capitalisation of .
Here are the trading details for Health-Chem:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: HCLC
Based on an overall assessment of its quality, value and momentum Health-Chem is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Health-Chem. Over the past six months, its share price has underperformed the S&P500 Index by -12.88%.
As of the last closing price of $0.00, shares in Health-Chem were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Health-Chem PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Health-Chem's directors